Veronica Garabelli //January 28, 2013//
Two Richmond –based companies are joining forces to create a new scientific process that uses advanced imaging to measure biological information.
Health Diagnostic Laboratory Inc. and Global Genomics Group partnership aims to detect human susceptibility to cardiovascular disease through the discovery of genetic biomarkers.
G3 is a life sciences company focused on a mission to discover “novel therapeutic and diagnostic targets for atherosclerotic disease.”
HDL provides clinical lab testing and disease management services.
-